The vision behind the formation of Augma Biomaterials originated from the inspiration of the developer, Dr. Amos Yahav, D.M.D, to find a bone graft substitute that could serve clinicians on a broader spectrum of indications, based on motivation to find the ultimate one.
Dr. Amos Yahav, D.M.D, is the Chairman of the Board and Founder of Augma Biomaterials Ltd.
From his practical knowledge, highly experienced background and after handling a vast number of cases, Dr. Yahav began to revive his vision to combine simplicity, efficiency and proven results in the dental surgery field.
Dr. Yahav is known worldwide for the revolutionary products he invented, which aim to improve the results of oral augmentation process results. In April 2019, Dr. Yahav recieved the Thomas Edison Award for his innovation and contribution.
The company continues to operate under these principles in order to bring further developments and innovation to the dental field, all for the benefit of the clinician and the patient.